Abstract
Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established. Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8 + T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients. Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function.
All Related Versions
Funding Information
  • European Foundation for the Study of Diabetes (2017-2019)
  • European Foundation for the Study of Diabetes (Rising Star award)
  • European Foundation for the Study of Diabetes (EFSD/Lilly European Diabetes Research Programme)
  • FP7 People: Marie-Curie Actions (PCOFUND-2012-600396)
  • Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (IJC2018-035390-I)
  • Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (BES-2017-079711)
  • Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (SAF2015-74112-JIN)
  • Ministerio de Ciencia e Innovación (PRE2020-092784)
  • Ministerio de Ciencia e Innovación (PID2019-104399RB-I00)
  • Ministerio de Ciencia e Innovación (PGC2018-097019-B-I00)
  • Ministerio de Ciencia e Innovación (SAF2016-79126-R)
  • Ministerio de Ciencia e Innovación (PID2019-104399RB-I00)
  • Ministerio de Ciencia e Innovación (IMPACT-2021. Instituto de Salud Carlos III.)
  • Ministerio de Ciencia e Innovación (PDC2021-121147-I00)
  • Ministerio de Ciencia e Innovación (RED2022-134397-T)
  • Ministerio de Ciencia e Innovación (Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033))
  • Ministerio de Universidades (FPU17/03847)
  • Fundación Científica Asociación Española Contra el Cáncer (INVES20026LEIV)
  • Fundación Científica Asociación Española Contra el Cáncer (AECC PROYE19047SABI)
  • European Molecular Biology Organization (EMBO YIP)
  • European Molecular Biology Organization (YIP)
  • European Research Council (FP7/2007-2013 (ERC 260464))
  • Fundación BBVA ((Investigadores-BBVA-2017) IN[17]_BBM_BAS_0066)
  • Comunidad de Madrid (IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-3733)
  • Ministerio de Ciencia, Innovación y Universidades (PID2022-138525OB-I00 2023- 26)

This publication has 49 references indexed in Scilit: